---

---

symbols : Azn    crawled time : 15:00   

save search

---

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 3.69% | O: 0.24% H: 0.42% C: 0.42%
NVO | News | $128.64 2.7% -1.0% 3.5M |

Health Technology

| 3.3% | O: -0.84% H: 0.86% C: -0.62%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| 4.14% | O: -0.56% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| -1.56% | O: -0.21% H: 0.11% C: -3.05%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 3.79% | O: -0.18% H: 0.84% C: 0.6%
report reach therapeutics market

---

Silicon carbide (SiC) market size to grow at a CAGR of 12.33% from 2022 to 2027, Increase in demand for SiC fibers in the aerospace sector to boost the market, Technavio
Published: 2024-03-11 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 7.0% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.49 -0.42% -1.11% 480K |

Manufacturing

| -10.64% | O: -1.41% H: 5.06% C: 4.01%
DOW | $56.74 -0.44% 0.34% 2.4M |

Process Industries

| 0.23% | O: 0.14% H: 1.95% C: 1.31%
ABT | News | $107.59 0.49% 0.33% 3.1M |

Health Technology

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 6.54% | O: 1.08% H: 0.82% C: 0.67%
market

---

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 8.63% | O: 3.06% H: 0.0% C: -2.34%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| -3.96% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -5.17% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $234.47 0.18% 0.16% 520K |

Health Technology

| 3.28% | O: -0.48% H: 1.17% C: -1.04%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 7.63% | O: 0.38% H: 0.44% C: -0.23%
reach research market

---

Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published: 2023-11-10 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 10.59% | O: 0.1% H: 0.0% C: -2.14%
ALPMY | News | $9.49 -0.42% -1.11% 480K |

Manufacturing

| -19.44% | O: -3.48% H: 3.87% C: 3.61%
PFE | News 4 | $26.32 0.23% 0.15% 20M |

Health Technology

| -11.32% | O: 0.24% H: 0.22% C: -0.91%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -0.24% | O: -1.24% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -2.82% | O: 0.4% H: 0.18% C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| 22.82% | O: 0.44% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 10.55% | O: -1.33% H: 0.22% C: -0.11%
report research market

---

Global Sustained Release Excipients Markets, 2017-2022, 2022-2027F, 2032F: Escalating Demand for Advanced Drug Formulations, Fueled by Higher Prevalence of Chronic and Acute Diseases
Published: 2023-09-29 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| 7.04% | O: -0.03% H: 0.0% C: -1.26%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 3.05% | O: 0.66% H: 0.0% C: -1.46%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| -3.39% | O: 1.18% H: 0.06% C: -1.62%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| 13.48% | O: 0.52% H: 0.37% C: -0.77%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 5.09% | O: 2.02% H: 0.0% C: -1.54%
drug global

---

Global Cardiovascular and Cerebrovascular Diseases Market Research Analysis 2023-2029: Sizeable Cardiovascular Market Shows Slower Growth Amid Patent Expirations and Generics' Rise
Published: 2023-08-30 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 0.86% | O: 0.56% H: 0.0% C: -2.26%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -9.12% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% 0.33% 3.1M |

Health Technology

| 4.12% | O: 0.73% H: 0.96% C: 0.32%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -12.84% | O: 0.66% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 2.47% | O: 0.46% H: 0.17% C: -0.86%
patent research global cardiovascular growth market

---

Infrastructure as a Service (IaaS) Market Size is Projected to Reach USD 482 Billion by 2030, Growing at a CAGR of 25.35%: Facts & Factors
Published: 2023-05-10 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| -5.9% | O: 0.63% H: 0.64% C: 0.64%
ORCL | News | $115.09 0.49% 0.1% 4.4M |

Technology Services

| 19.71% | O: 0.68% H: 0.91% C: 0.75%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -7.07% | O: 0.09% H: 0.48% C: 0.28%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| 72.52% | O: -0.54% H: 2.89% C: 2.31%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -27.96% | O: 0.25% H: 1.14% C: 0.47%
BHC | $8.53 0.95% 0.0% 4M |

Health Technology

| 45.56% | O: 0.68% H: 1.53% C: 0.85%
BABA | $72.51 2.59% 2.0% 15M |

Retail Trade

| -11.81% | O: -0.1% H: 2.87% C: 0.99%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| 15.47% | O: -0.21% H: 0.32% C: -0.07%
MSFT | News 4 | $407.57 1.65% 1.54% 11M |

Technology Services

| 32.76% | O: 0.53% H: 1.42% C: 1.2%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| -5.63% | O: -0.53% H: 0.5% C: 0.25%
AMGN | News | $273.54 0.6% 0.65% 1.9M |

Health Technology

| 16.68% | O: 0.2% H: 0.05% C: -0.33%
service reach growing market

---

Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
Published: 2023-03-07 (Crawled : 15:00) - biospace.com/
PSNL | $1.38 9.52% 9.03% 170K |

Health Technology

| -52.41% | O: 1.03% H: 7.76% C: 3.07%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 9.74% | O: 0.9% H: 0.28% C: -1.3%
research disease molecular

---

TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 9.78% | O: -2.3% H: 2.11% C: 1.78%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 11.47% | O: -0.31% H: 0.05% C: -0.33%
tezspire approved

---

HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
Published: 2023-01-18 (Crawled : 15:00) - globenewswire.com
HCM | $18.25 7.73% 6.92% 120K |

Health Technology

| 9.54% | O: 1.32% H: 4.49% C: 1.01%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 0.16% | O: 1.36% H: 0.33% C: -1.13%
orpathys drug agreement china

---

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| 13.01% | O: 1.13% H: 0.0% C: 0.0%
SNYNF | News | $94.25 1.67% -2.18% 480 |

Health Technology

| -2.08% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 3.84% | O: 1.08% H: 0.0% C: -0.25%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 7.93% | O: -0.01% H: 0.08% C: -0.95%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| 17.39% | O: -0.37% H: 0.89% C: 0.4%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -3.07% | O: -0.39% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 4.04% | O: -0.46% H: 0.38% C: 0.01%
global report sanofi market

---

Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480 |

Health Technology

| -2.08% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 3.84% | O: 1.08% H: 0.0% C: -0.25%
PFE | News 4 | $26.32 0.23% 0.15% 20M |

Health Technology

| -48.72% | O: -0.08% H: 0.21% C: -0.1%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 7.93% | O: -0.01% H: 0.08% C: -0.95%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -15.71% | O: -0.04% H: 0.16% C: -0.47%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -32.05% | O: 0.04% H: 0.21% C: -0.25%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -3.07% | O: -0.39% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 3.6M |

Health Technology

| -21.38% | O: 0.08% H: 0.66% C: 0.61%
EXEL | $23.29 1.84% 1.82% 1.9M |

Health Technology

| 48.72% | O: -0.32% H: 2.91% C: 2.75%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 4.04% | O: -0.46% H: 0.38% C: 0.01%
global disease report therapeutics cancer market

---

ENHERTU® Achieved Statistically Significant Overall Survival Reducing the Risk of Death by 36% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast03
Published: 2022-12-07 (Crawled : 15:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 3.34% | O: 0.45% H: 0.64% C: -0.03%
enhertu risk breast positive cancer her2- her2 metastatic breast cancer

---

Fortress Biotech to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
Published: 2022-12-06 (Crawled : 15:00) - biospace.com/
FBIO | $1.81 3.43% 2.23% 190K |

Health Technology

| 156.99% | O: -2.03% H: 2.9% C: -3.67%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 3.55% | O: -0.48% H: 1.59% C: 0.69%
conference biotech medical aesthetic

---

Global Opioid Induced Constipation Drugs Market Report to 2030 - by Drug Type, Prescription Type and Region
Published: 2022-09-28 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 31.74% | O: 2.35% H: 0.0% C: -0.68%
PFE | News 4 | $26.32 0.23% 0.15% 20M |

Health Technology

| -40.3% | O: 1.32% H: 0.31% C: -0.54%
IRWD | $8.31 3.1% 2.95% 2.5M |

Health Technology

| -19.08% | O: 1.07% H: 3.08% C: 2.41%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 33.08% | O: 0.04% H: 3.14% C: 2.68%
drug global opioid report market

---

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| -28.95% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 11.7% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -15.57% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| -3.67% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| 134.87% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 11.54% | O: 0.54% H: 2.78% C: 2.69%
life disease

---

Global Industry Analysts Predicts the World Mobile Medical Apps Market to Reach $16.6 Billion by 2026
Published: 2022-03-22 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| -12.02% | O: 0.9% H: 0.0% C: -8.17%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 15.2% | O: 2.88% H: 2.09% C: 2.09%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 14.06% | O: -0.93% H: 0.0% C: 0.0%
MDT | $81.29 0.89% -0.11% 4.1M |

Health Technology

| -25.83% | O: -0.53% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| -4.34% | O: 0.79% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -31.45% | O: -0.41% H: 0.0% C: 0.0%
BSX | $68.99 1.43% 2.74% 8M |

Health Technology

| 55.66% | O: 0.02% H: 0.59% C: -1.33%
ABT | News | $107.59 0.49% 0.33% 3.1M |

Health Technology

| -11.71% | O: 0.07% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -8.82% | O: 0.15% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 12.07% | O: 0.51% H: 0.0% C: 0.0%
mobile

---

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Published: 2022-01-03 (Crawled : 15:00) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 21.1% | O: 2.49% H: 1.06% C: -2.49%
GNPX | $2.31 6.8% 6.77% 30K |

Health Technology

| 76.34% | O: 16.79% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 21.63% | O: 0.03% H: 0.17% C: 0.07%
keytruda fast track designation treatment fda fast track gene therapy cel fda fast track lung cancer therapy cancer designation

---

With Market Size Valued at $2.8 Billion by 2026, it`s a Healthy Outlook for the Global Cancer Cachexia Market
Published: 2021-11-03 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 10.95% | O: 1.95% H: 0.06% C: 0.06%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| 194.14% | O: 2.72% H: 0.0% C: 0.0%
AVEO | $15.0 0.0% 0 |

Health Technology

| 112.39% | O: -0.14% H: 3.12% C: 2.55%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 12.48% | O: 1.52% H: 0.19% C: -0.19%
cancer

---

New Analysis from Global Industry Analysts Reveals Steady Growth for Novel Drug Delivery Systems (NDDS), with the Market to Reach $28.1 Billion Worldwide by 2026
Published: 2021-10-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| 1.82% | O: 2.4% H: 0.1% C: 0.1%
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 16.65% | O: -0.35% H: 1.78% C: 1.78%
PFE | News 4 | $26.32 0.23% 0.15% 20M |

Health Technology

| -37.36% | O: 1.19% H: 1.03% C: 0.52%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -6.41% | O: 0.07% H: 1.62% C: 0.82%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| 8.16% | O: 0.42% H: 1.4% C: 0.97%
ABT | News | $107.59 0.49% 0.33% 3.1M |

Health Technology

| -7.64% | O: 0.91% H: 0.99% C: 0.31%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 18.36% | O: -0.48% H: 1.8% C: 1.34%
drug growth drug delivery liver

---

Gainers vs Losers

77%

23%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 26M |

AGBA | $2.97 137.6% 57.48% 66M |

Finance

EDBL | News | $6.59 75.27% 41.8% 2M |

ZAPP | $4.44 50.2% 33.12% 370K |

n/a

MTC | $2.24 43.59% 30.67% 6M |

Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M |

Finance

SHIM | $3.045 35.33% 26.23% 870K |

HKIT | $1.33 30.39% 24.16% 390K |

Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M |

Wholesale Trade

OST | $0.5 25.0% 21.88% 280K |

---

Your saved searches

---